## **Core Concept**
Gluten-sensitive enteropathy, also known as celiac disease, is a chronic autoimmune disorder primarily affecting the small intestine. It is triggered by the ingestion of gluten in genetically predisposed individuals. The condition involves an immune response to gluten, leading to inflammation and damage in the intestinal mucosa.

## **Why the Correct Answer is Right**
The correct answer, **HLA-DQ2**, is strongly associated with gluten-sensitive enteropathy (celiac disease) because it is the genetic marker found in the majority of patients with this condition. The HLA-DQ2 and HLA-DQ8 genotypes are considered necessary but not sufficient for the development of celiac disease. These genetic markers are involved in the presentation of gluten peptides to T-cells, which then triggers an immune response against the intestinal mucosa.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While certain genetic markers are associated with an increased risk of various autoimmune diseases, **HLA-DR4** is more commonly linked with rheumatoid arthritis rather than gluten-sensitive enteropathy.
- **Option B:** **HLA-DQ8** is also associated with celiac disease but to a lesser extent than **HLA-DQ2**. It is found in a smaller proportion of patients with the condition.
- **Option D:** **HLA-DR3** is associated with several autoimmune conditions but is not as strongly linked with gluten-sensitive enteropathy as **HLA-DQ2**.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that patients with celiac disease are at increased risk of developing other autoimmune disorders, and screening for celiac disease is recommended in patients with type 1 diabetes, autoimmune thyroid disease, and other autoimmune conditions. The presence of **HLA-DQ2** or **HLA-DQ8** can help in diagnosing or ruling out celiac disease in susceptible individuals.

## **Correct Answer:** . **HLA-DQ2**